# Evaric Pharmaceuticals Inc. – FDA Inspection, May 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/evaric-pharmaceuticals-inc/3909e477-38cc-417f-888c-e683286c4897
Source feed: FDA_Inspections

> FDA inspection 1270045 of Evaric Pharmaceuticals Inc., May 16, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1270045
- Company Name: Evaric Pharmaceuticals Inc.
- Inspection Date: 2025-05-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1091300 - 2019-05-29](https://www.keypedia.com/records/fda_inspections/evaric-pharmaceuticals-inc/068acee6-2c64-4678-8352-8af0ecd7e53c)
- FDA Inspection 999784 - 2017-02-07

## Related Officers

- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)
- [Issuing Officer](https://www.keypedia.com/people/luxuly-abraham/d33e3164-ec89-488b-bab9-a9ec30544970)

Company: https://www.keypedia.com/companies/evaric-pharmaceuticals-inc/0f29a015-1b48-40b9-a0a7-04ec9c3e15b4

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d
